Morbidity involving the hallucinogenic designer amines MDA and 2C-I

Journal of Forensic Sciences

Volumn 54, Issue 6, 2009, Pages 1485-1487

  Drees, Julia C ^a   Stone, Judy A ^a,b   Wu, Alan H B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

2C I; Forensic science; Hemorrhagic stroke; Liquid chromatography tandem mass spectrometry; MDA; Moyamoya

Indexed keywords

2C I; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; COCAINE; METHADONE; METHAMPHETAMINE; OPIATE; OXYCODONE; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGITATION; ALCOHOL CONSUMPTION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; DRUG URINE LEVEL; EMERGENCY WARD; FEMALE; GAS CHROMATOGRAPHY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTHERMIA; IMMUNOASSAY; INTENSIVE CARE UNIT; LIQUID CHROMATOGRAPHY; MENTAL HEALTH; MORBIDITY; MOYAMOYA DISEASE; NEUROSURGERY; PREVALENCE; PRIORITY JOURNAL; QUADRIPLEGIA; QUANTITATIVE ANALYSIS; SEIZURE; STROKE; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; TOXICOLOGY; TRACHEOSTOMY; URINALYSIS; URINE INCONTINENCE; VASOCONSTRICTION; VOMITING;

3,4-METHYLENEDIOXYAMPHETAMINE; ADULT; CHROMATOGRAPHY, GAS; DESIGNER DRUGS; DIMETHOXYPHENYLETHYLAMINE; FEMALE; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALLUCINOGENS; HUMANS; INTRACRANIAL HEMORRHAGES; MOYAMOYA DISEASE; QUADRIPLEGIA; STROKE; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 70350493419     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2009.01199.x     Document Type: Article

References (12)

1. Shulgin A, Shulgin A. Pihkal: a chemical love story. Berkley, CA : Transform Press, 1991.
2. Giroud C, Augsburger M, Rivier L, Mangin P, Sadeghipour F, Varesio E, et al. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market. J Anal Toxicol 1998 22 : 345 354.
3. Villalobos CA, Bull P, Saes P, Cassels BK, Huidobro-Toro JP. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. Br J Pharmacol 2004 141 : 1167 1174.
4. Stafford P. Psychedelics encyclopedia. Berkeley : Ronin Publishing, 1992.
5. Kalasinsky KS, Hugel J, Kish SJ. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). J Forensic Sci 2004 49 : 1106 1112.
6. http://www.erowid.org/chemicals/mda/mda-effects.shtml (accessed on October 15, 2008).
7. Auer J, Berent R, Weber T, Lassnig E, Eber B. Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult. Neurol Sci 2002 23 : 199 201.
8. McEvoy AW, Kitchen ND, Thomas DGT. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg 1980 14 : 449 454.
9. Pichini S, Pujadas M, Marchei E, Pellegrini M, Fiz J, Pacifici R, et al. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. J Pharm Biomed Anal 2008 47 : 335 342.
10. Theobald DS, Putz M, Schneider E, Maurer HH. New designer drug 4-iodo-2,5-dimethoxy-bphenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J Mass Spectrom 2006 41 : 872 886.
11. Baselt RC. Disposition of toxic drugs and chemicals in man, 7th edn. Foster City, CA : Biomedical Publications, 2004.
12. Hall AP, Henry JA. Acute toxic effects of "Ecstasy" (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006 6 : 678 685.